A high-entropy nanozyme-based photothermal-adjuvant in situ nanovaccine for potentiated tumor immunotherapy
Source abstract
Abstract
A qPBA nanocube-based HEzyme as a photothermal-adjuvant ICD-driven in situ nanovaccine was developed for potentiated tumor immunotherapy via ROS amplification and TAM repolarization.
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Advanced Photocatalysis Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, P.R. China
Department of Clinical Trial Research Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100005, China
Funding
Natural Science Foundation of Beijing Municipality · Beijing Municipal Commission of Education
References (42)
Show source-provided references
1. Rui · Front. Immunol. · 2023 · 14 · 121247610.3389/fimmu.2023.1212476 ↗
2. Zaidi · J. Clin. Invest. · 2018 · 129 · 4610.1172/JCI126046 ↗
3. Dagher · Cell · 2023 · 186 · 181410.1016/j.cell.2023.02.039 ↗
4. Appleton · Front. Immunol. · 2021 · 12 · 75443610.3389/fimmu.2021.754436 ↗
5. Labanieh · Nature · 2023 · 614 · 63510.1038/s41586-023-05707-3 ↗
6. Maalej · Mol. Cancer · 2023 · 22 · 2010.1186/s12943-023-01723-z ↗
7. Gong · Nat. Rev. Drug Discovery · 2024 · 23 · 60710.1038/s41573-024-00974-9 ↗
8. Zhang · Innovation · 2021 · 2 · 100174
9. Galluzzi · Nat. Rev. Drug Discovery · 2024 · 23 · 44510.1038/s41573-024-00920-9 ↗
10. Krysko · Nat. Rev. Cancer · 2012 · 12 · 86010.1038/nrc3380 ↗
11. Pei · Chem. Soc. Rev. · 2023 · 52 · 203110.1039/D2CS00352J ↗
12. Sen · Chem. Soc. Rev. · 2022 · 51 · 121210.1039/D1CS00417D ↗
13. Shen · Adv. Mater. · 2023 · 36 · 221115110.1002/adma.202211151 ↗
14. Zhang · Adv. Mater. · 2023 · 36 · 221114710.1002/adma.202211147 ↗
15. Xu · Adv. Mater. · 2020 · 32 · 200356310.1002/adma.202003563 ↗
16. Chao · Nat. Rev. Bioeng. · 2023 · 1 · 12510.1038/s44222-022-00004-6 ↗
17. Xu · Nano TransMed. · 2024 · 3 · 10004510.1016/j.ntm.2024.100045 ↗
18. Wang · Nano TransMed. · 2024 · 3 · 10003210.1016/j.ntm.2024.100032 ↗
19. Ding · Adv. Mater. · 2024 · 36 · 240136110.1002/adma.202401361 ↗
20. Ai · Adv. Mater. · 2023 · 35 · 230233510.1002/adma.202302335 ↗
21. Li · Adv. Funct. Mater. · 2023 · 33 · 230271210.1002/adfm.202302712 ↗
22. Yao · Science · 2022 · 376 · eabn310310.1126/science.abn3103 ↗
23. Kumar Katiyar · Nano Energy · 2021 · 88 · 10626110.1016/j.nanoen.2021.106261 ↗
24. Jana · Adv. Mater. · 2022 · 36 · 220640110.1002/adma.202206401 ↗
25. Yang · Adv. Sci. · 2024 · 11 · 240614910.1002/advs.202406149 ↗
26. Feng · Adv. Sci. · 2023 · 10 · 230307810.1002/advs.202303078 ↗
27. He · Adv. Mater. · 2024 · 36 · 240092010.1002/adma.202400920 ↗
28. Sun · Chem. Soc. Rev. · 2024 · 53 · 440010.1039/D3CS00954H ↗
29. Liang · Chem. Soc. Rev. · 2024 · 53 · 602110.1039/D4CS00034J ↗
30. He · Nanoscale · 2023 · 15 · 1281810.1039/D3NR01741A ↗
31. Tao · J. Nanobiotechnol. · 2022 · 20 · 110.1186/s12951-021-01235-2 ↗
32. Wang · ACS Nano · 2023 · 17 · 1958110.1021/acsnano.3c07775 ↗
33. Wang · Adv. Mater. · 2023 · 36 · 230545310.1002/adma.202305453 ↗
34. Hsu · Nat. Rev. Chem. · 2024 · 8 · 47110.1038/s41570-024-00602-5 ↗
35. Yin · Biomater. Adv. · 2024 · 164 · 21399610.1016/j.bioadv.2024.213996 ↗
36. Li · ACS Nano · 2021 · 15 · 518910.1021/acsnano.0c10388 ↗
37. Veglak · J. Am. Chem. Soc. · 2024 · 146 · 1952110.1021/jacs.4c06412 ↗
38. Wang · npj Precis. Oncol. · 2024 · 8 · 3110.1038/s41698-024-00522-z ↗
39. Zheng · Adv. Funct. Mater. · 2021 · 32 · 210897110.1002/adfm.202108971 ↗
40. Xiang · Signal Transduction Targeted Ther. · 2021 · 6 · 7510.1038/s41392-021-00484-9 ↗
41. Wang · Bioact. Mater. · 2022 · 16 · 418
42. Wu · Chem. Soc. Rev. · 2024 · 53 · 264310.1039/D3CS00673E ↗